This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for topical pain management drugs. The geographical scope of this study is global. Opioid and non-opioid topical pain relief drugs have been analyzed in the report, and types of pain, treatment guidelines and demand for addressing different types of pain have been included in the scope of the study. The market size estimates include both branded and generic drugs.
This report details market shares of topical pain management drugs based on therapeutic class, mode of purchase and geography.
Based on therapeutic class, the market is segmented into non-opioids and opioids. Non-opioids are further segmented into nonsteroidal anti-inflammatory drugs (NSAIDS), capsaicin, lidocaine and others.
Based on mode of purchase, the market is segmented into over-the-counter (OTC) and prescription drugs.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data have been provided for 2019 as the base year, with forecasts for 2020 through 2025. Estimated values are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
The report Includes:
- 29 data tables and 21 additional tables
- An overview of the global topical pain relief market
- Analysis of the global market trends, with data from 2019 and 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Comprehensive analysis of the current and future market potential of topical pain management drugs
- Examination of the competitive environment, regulatory scenario and technological advancements which are influencing the growth of generic drugs market
- Assessment of long-term versus short-term impact of the COVID-19 pandemic on the global topical pain relief market compared to overall pharmaceuticals industry
- Competitive landscape analysis of the key players in the global topical pain relief market and pipeline of select topical pain management drugs
- Key M&A deals, collaborations, agreements, partnerships, and joint ventures within the global topical pain treatment market
- Profiles of the leading market players, including GlaxoSmithKline, Sanofi S.A., Johnson & Johnson, Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- History of Pain and Pain Treatment
- Types of Pain
- Acute Pain
- Chronic Pain
- How Pain is Treated
- Overview: Topical Pain Management Drugs
- Limitation of Topical Drugs
- Future Perspectives
- Prevalence of Chronic Pain
Chapter 4 Market Dynamics
- Market Drivers
- Increasing Incidences of Acute and Chronic Pain
- Growth of Geriatric Populations and Related Orthopedic Surgeries
- Rising Cases of Sports-related Injuries
- Emerging Non-opioid Drugs for Pain Management
- Market Restraints
- Side Effects of Topical Pain Relief Drugs
- High Cost of Drug Development and Pricing Pressures on Manufacturers
- Market Opportunities
- Launches of New Topical Drugs for Pain Management
Chapter 5 Impact of COVID-19 on the Market
- Overview
- Short-Term Impact on the Pharma Industry
- Long-Term Impact on the Pharma Industry
- COVID-19 and Pain Management
- Telemedicine
Chapter 6 Market Breakdown by Therapeutic Class
- Introduction
- Non-opioids
- Market Size and Forecast
- Market Analysis
- Opioids
- Market Size and Forecast
- Market Analysis
Chapter 7 Market Breakdown by Mode of Purchase
- Introduction
- Prescription Based
- Market Size and Forecast
- Market Analysis
- Over-the-Counter
- Market Size and Forecast
- Market Analysis
Chapter 8 Market Breakdown by Region
- Introduction
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Rest of the World
- Market Size and Forecast
Chapter 9 Industry Developments
- Competitive Landscape
- Pharmaceutical Pipeline
- Agreements, Collaborations and Partnerships
Chapter 10 Company Profiles
- Advacare Pharma
- Endo International Plc
- Glaxosmithkline
- Grunenthal Gmbh
- Johnson & Johnson
- Reckitt Benckiser Group Plc
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Topical Biomedics
Chapter 11 Appendix: Terminology, Acronyms and Sources of Information
- U.S. Pain Societies and Associations
- International Associations and Organizations
List of Tables
Summary Table A: Global Market for Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Summary Table B: Global Market for Non-opioid Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 1: Uses of Topical Analgesics
Table 2: Prevalence of Pain, by Country
Table 3: Prevalence of Chronic Pain and Percentage of Population Affected, by Country, 2018
Table 4: Global Population Growth, by Age Group, Through 2050
Table 5: Sports Injuries, by Age Group in the U.S., 2019
Table 6: Coronavirus Reported Cases and Deaths, by Country,2020
Table 7: Impact of COVID-19 on the Treatment of Chronic Pain
Table 8: Global Market for Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 9: Global Market for Non-opioid Topical Pain Management Drugs, by Region, Through 2025
Table 10: Global Market for Non-opioid Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 11: Topical NSAIDs
Table 12: Global Market for Opioid Topical Pain Management Drugs, by Region, Through 2025
Table 13: Products Categorized into OTC and Prescription Drugs
Table 14: Global Market for Topical Pain Management Drugs, by Mode of Purchase, Through 2025
Table 15: Global Market for Prescription-Based Topical Pain Management Drugs, by Region, Through 2025
Table 16: Global Market for Over-the-Counter Topical Pain Management Drugs, by Region, Through 2025
Table 17: Global Market for Topical Pain Management Drugs, by Region, Through 2025
Table 18: North American Market for Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 19: North American Market for Non-opioid Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 20: North American Market for Topical Pain Management Drugs, by Mode of Purchase, Through 2025
Table 21: North American Market for Topical Pain Management Drugs, by Country, Through 2025
Table 22: European Market for Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 23: European Market for Non-opioid Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 24: European Market for Topical Pain Management Drugs, by Mode of Purchase, Through 2025
Table 25: European Market for Topical Pain Management Drugs, by Country, Through 2025
Table 26: Asia-Pacific Market for Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 27: Asia-Pacific Market for Non-opioid Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 28: Asia-Pacific Market for Topical Pain Management Drugs, by Mode of Purchase, Through 2025
Table 29: Asia-Pacific Market for Topical Pain Management Drugs, by Country, Through 2025
Table 30: Rest of the World Market for Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 31: Rest of the World Market for Non-opioid Topical Pain Management Drugs, by Therapeutic Class, Through 2025
Table 32: Rest of the World Market for Topical Pain Management Drugs, by Mode of Purchase, Through 2025
Table 33: Select Topical Pain Management Drug Pipelines
Table 34: First Time Prescription Generic Pain Management and Approvals, April 2005-July 2020
Table 35: AdvaCare Pharma: Topical Pain Management Drugs Product Portfolio
Table 36: Endo Pharmaceuticals Inc.: Topical Pain Management Drugs Product Portfolio
Table 37: GlaxoSmithKline PLC: Topical Pain Management Drugs Product Portfolio
Table 38: Grünenthal: Topical Pain Management Drugs Product Portfolio
Table 39: Johnson & Johnson: Topical Pain Management Drugs Product Portfolio
Table 40: Reckitt Benckiser Group: Topical Pain Management Drugs Product Portfolio
Table 41: Sanofi: Topical Pain Management Drugs Product Portfolio
Table 42: Sun Pharmaceuticals Industries Ltd.: Topical Pain Management Drugs Product Portfolio
Table 43: Teva Pharmaceutical Industries Ltd.: Topical Pain Management Drugs Product Portfolio
Table 44: Topical BioMedics: Topical Pain Management Drugs Product Portfolio
Table 45: Glossary of Terms Used in Pain Management Drug and Device Markets
Table 46: Acronyms Used in This Report
Table 47: U.S. Pain Societies and Associations
Table 48: International Associations and Organizations
List of Figures
Summary Figure: Global Market Shares of Topical Pain Management Drugs, by the Mode of Purchase, 2019
Figure 1: Pain Management Techniques
Figure 2: Percentage Population Affected by Chronic Pain, 2018
Figure 3: Prevalence Rates of Chronic Pain, by Age Groups, 2015 and 2016
Figure 4: Global Population Growth, by Age Group, 2000-2050
Figure 5: U.S. Population Engaged in Sports and Exercise Per Day, 2010-2019
Figure 6: Identified Non-opioid Drug Distribution, by Indication, 2017
Figure 7: Impact of COVID-19 on Pharma Industry
Figure 8: Global Market Shares of Topical Pain Management Drugs, by Therapeutic Class, 2019
Figure 9: Global Market for Non-opioid Topical Pain Management Drugs, 2019-2025
Figure 10: Global Market for Non-opioid Topical Pain Management Drugs, by Region, 2019-2025
Figure 11: Global Market Shares of Non-opioid Topical Pain Management Drugs, by Therapeutic Class, 2019
Figure 12: Global Market for Opioid Topical Pain Management Drugs, 2019-2025
Figure 13: Global Market for Opioid Topical Pain Management Drugs, by Region, 2019-2025
Figure 14: Global Market Shares of Topical Pain Management Drugs, by Mode of Purchase, 2019
Figure 15: Global Market for Prescription-Based Topical Pain Management Drugs, 2019-2025
Figure 16: Global Market for Prescription-Based Topical Pain Management Drugs, by Region, 2019-2025
Figure 17: Global Market for Over-the-Counter Topical Pain Management Drugs, 2019-2025
Figure 18: Global Market for Over-the-Counter Topical Pain Management Drugs, by Region, 2019-2025
Figure 19: Global Market Shares of Topical Pain Management Drugs, by Region, 2019
Figure 20: North American Market Shares of Topical Pain Management Drugs, by Therapeutic Class, 2019
Figure 21: North American Market Shares of Topical Pain Management Drugs, by Mode of Purchase, 2019
Figure 22: North American Market Shares of Topical Pain Management Drugs, by Country, 2019
Figure 23: U.S. Market for Topical Pain Management Drugs, 2019-2025
Figure 24: Canadian Market for Topical Pain Management Drugs, 2019-2025
Figure 25: European Market Shares of Topical Pain Management Drugs, by Therapeutic Class, 2019
Figure 26: European Market Shares of Topical Pain Management Drugs, by Mode of Purchase, 2019
Figure 27: European Market Shares of Topical Pain Management Drugs, by Country, 2019
Figure 28: German Market for Topical Pain Management Drugs, 2019-2025
Figure 29: U.K. Market for Topical Pain Management Drugs, 2019-2025
Figure 30: French Market for Topical Pain Management Drugs, 2019-2025
Figure 31: Italian Market for Topical Pain Management Drugs, 2019-2025
Figure 32: Spanish Market for Topical Pain Management Drugs, 2019-2025
Figure 33: Rest of European Market for Topical Pain Management Drugs, 2019-2025
Figure 34: Asia-Pacific Market Shares of Topical Pain Management Drugs, by Therapeutic Class, 2019
Figure 35: Asia-Pacific Market Shares of Topical Pain Management Drugs, by Mode of Purchase, 2019
Figure 36: Asia-Pacific Market Shares of Topical Pain Management Drugs, by Country, 2019
Figure 37: Chinese Market for Topical Pain Management Drugs, 2019-2025
Figure 38: Japanese Market for Topical Pain Management Drugs, 2019-2025
Figure 39: Indian Market for Topical Pain Management Drugs, 2019-2025
Figure 40: Rest of Asia-Pacific Market for Topical Pain Management Drugs, 2019-2025
Figure 41: Rest of the World Market Shares of Topical Pain Management Drugs, by Therapeutic Class, 2019
Figure 42: Rest of the World Market Shares of Topical Pain Management Drugs, by Mode of Purchase, 2019
Figure 43: Endo Pharmaceuticals Inc.: Annual Revenue, 2016-2019
Figure 44: Endo Pharmaceuticals Inc.: Revenue Share, by Established Product, 2019
Figure 45: GlaxoSmithKline PLC: Annual Revenue, 2016-2019
Figure 46: GlaxoSmithKline PLC: Revenue Share, by Consumer Healthcare, 2019
Figure 47: Grünenthal: Annual Revenue, 2016-2019
Figure 48: Johnson & Johnson: Annual Revenue, 2016-2019
Figure 49: Johnson & Johnson: Revenue Share, by Region/Country, 2019
Figure 50: Johnson & Johnson: Revenue Share, by Business Unit, 2019
Figure 51: Reckitt Benckiser Group: Annual Revenue, 2016-2019
Figure 52: Reckitt Benckiser Group: Revenue Share, by Region/Country, 2019
Figure 53: Reckitt Benckiser Group: Revenue Share, by Operating Segment, 2019
Figure 54: Sanofi: Annual Revenue, 2016-2019
Figure 55: Sanofi: Revenue Share, by Region/Country, 2019
Figure 56: Sanofi: Revenue Share, by Business Segment, 2019
Figure 57: Sun Pharmaceuticals Industries Ltd.: Financial Performance, 2016-2019
Figure 58: Sun Pharmaceuticals Industries Ltd.: Revenue Share, by Business Segment, 2019
Figure 59: Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2016-2019
Samples
LOADING...
Executive Summary
Growth of the global market is attributed to factors such as the growing prevalence of cancer, diabetes and other chronic diseases; and strong investment in research and development activities by key market players including GlaxoSmithKline, SanofiS.A., Johnson& Johnson, SunPharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd., among others.
The increasing incidence of acute and chronic pain and rising geriatric populations with osteoporosis-related issues are the major factors likely to fuel the market for topical pain management drugs.
According to the Global Burden of Disease Study 2016, the high prominence of pain and pain-related diseases is the leading cause of disability and disease burden globally. In 2016, the burden of chronic pain increased, with 1.9 billion people with symptomatic chronic conditions. The burden of chronic pain is likely to drive the market for topical pain management drugs during the forecast period.
The global topical pain management drugs market is segmented based on therapeutic class, mode of purchase and region.
Companies Mentioned
- Advacare Pharma
- Endo International Plc
- Glaxosmithkline
- Grunenthal Gmbh
- Johnson & Johnson
- Reckitt Benckiser Group Plc
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Topical Biomedics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 122 |
| Published | April 2021 |
| Forecast Period | 2020 - 2025 |
| Estimated Market Value ( USD | $ 9.1 Billion |
| Forecasted Market Value ( USD | $ 12.5 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
